Publication:
How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018

dc.conference.dateJUN, 2018
dc.conference.locationBristol, England
dc.conference.organizerMeeting of the International-Consultation-on-Incontinence-Research-Society (ICI-RS)
dc.contributor.coauthorKhullar, Vik
dc.contributor.coauthorDigesu, G. Alessandro
dc.contributor.coauthorVeit-Rubin, Nikolaus
dc.contributor.coauthorSahai, Arun
dc.contributor.coauthorRahnama'i, Mohammad Sajjad
dc.contributor.coauthorChermansky, Christopher
dc.contributor.coauthorDmochowski, Roger
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberNo
dc.contributor.kuauthorTarcan, Tufan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:49:14Z
dc.date.issued2019
dc.description.abstractBackground: This paper summarises the discussion in a think tank at the International Consultation on Incontinence-Research Society (ICI-RS) 2018 about the treatment of bladder pain syndrome. Aims: To review the treatments of bladder pain syndrome from behavioural treatments to surgical interventions. Materials and Methods: Review the literature in the light of the think tank discussions. Results: All guidelines recommend different levels of treatment starting with conservative behavioral treatments then introducing oral treatments followed by intravesical instillations. If these treatments fail then more invasive treatments such as botulinum toxin injections, neuromodulation, or surgery could be suggested. Conclusion: Unfortunately for all treatments, the numbers are limited and, therefore, the evidence base is not strong. Further suggestions for research are suggested.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.volume38
dc.identifier.WoSQuartileQ3
dc.identifier.doi10.1002/nau.24245
dc.identifier.eissn1520-6777
dc.identifier.endpageS81
dc.identifier.issn0733-2467
dc.identifier.pubmed31821630
dc.identifier.scopus2-s2.0-85076367314
dc.identifier.startpageS71
dc.identifier.urihttps://doi.org/10.1002/nau.24245
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14340
dc.identifier.volume38
dc.identifier.wos000540355800010
dc.keywordsBotulinum toxin
dc.keywordsInterstitial cystitis
dc.keywordsIntravesical treatments
dc.keywordsNeuromodulation
dc.keywordsPainful bladder syndrome
dc.keywordsTreatment
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofNeurourology and Urodynamics
dc.subjectUrology
dc.subjectNephrology
dc.titleHow can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorTarcan, Tufan
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files